RxDoctor Payments Data

Mary Ann Webster, APRN

Family · East Granby, CTNPI 1093792160

Payments from drug & device makers

$2,388in general payments, 2019–2025

Across 114 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$416
  • Novo Nordisk$407
  • AstraZeneca$318
  • Lilly USA, LLC$252
  • Boehringer Ingelheim$184
  • Pfizer$160
  • plus $651 from 18 others

What the payments were for

  • Food & beverage$2,388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,388 in reported general payments places this provider in the 80th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$14,351
Medicare patients
77
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$18,659
EliquisApixaban12$11,280
Ajovy AutoinjectorFremanezumab-Vfrm14$9,616
Levothyroxine Sodium125$1,340
SynthroidLevothyroxine Sodium17$1,144
Atorvastatin Calcium114$1,105
Lisinopril132$960
Easy TouchSyringe-Needle,insulin,0.5 Ml19$793
Simvastatin95$728
Rosuvastatin Calcium38$638
Duloxetine Hcl18$630
Omeprazole35$626
Escitalopram Oxalate49$511
Tamsulosin Hcl23$498
Amlodipine Besylate57$477

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$407$18,65920 claims
PfizerEliquis$160$11,28012 claims
AbbVieSynthroid$416$1,14417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,596 family providers in Connecticut.

Other family in East Granby

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →